Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Mallinckrodt and Endo , drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in a deal ...
Drugmakers Mallinckrodt and Endo Are in Talks to Merge
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
Endo to divest international pharma unit for $99M
Endo Inc. said Tuesday it has entered into an agreement to divest its international pharmaceuticals business to Knight ...
Mallinckrodt to Take Over Endo in Deal Valued at $6.7 Billion
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said Thursday that Endo shareholders will receive a total of $80 million in cash and ...
Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
Wall Street Reacts Coolly to Endo-Mallinckrodt Deal
Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim v ...
Drugmakers Mallinckrodt, Endo in Talks to Merge, Source Says
Both Mallinckrodt and Endo have in the recent years faced lawsuits for their alleged role in the U.S. opioid epidemic. While ...
Reuters2d
Drugmakers Mallinckrodt, Endo in talks to merge, source says
March 12 (Reuters) - Mallinckrodt and Endo (NDOI.PK), opens new tab are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on ...